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Notch2 Is Preferentially Expressed
in Mature B Cells and Indispensable
for Marginal Zone B Lineage Development
sions during lymphocyte development. Using a condi-
tional gene-targeting approach, it has been shown that
the inactivation of Notch1 results in the blockade of
T cell development and ectopic B cell development in
the thymus (Radtke et al., 1999). RBP-J conditional
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To further investigate the function of Notch in lympho-Summary
cyte development, we created Notch2 cKO mice using
Cre-loxP-mediated site-specific recombination strategyThe Notch genes play a key role in cellular differentia-
tion. The significance of Notch1 during thymocyte de- (Kuhn et al., 1995). Here we show that the inactivation
of Notch2 did not affect T cell development. In contrast,velopment is well characterized, but the function of
Notch2 is poorly understood. Here we demonstrate MZB cells and CD1dhi fraction of T2 B cells in the spleen
were virtually absent in mice with Notch2-deficientthat Notch2 but no other Notch family member is pref-
erentially expressed in mature B cells and that condi- (Notch2/) B cells, while other B cell populations ap-
peared normal, implicating CD1dhi T2 B cells to be directtionally targeted deletion of Notch2 results in the de-
fect of marginal zone B (MZB) cells and their presumed precursors of MZB cells. We also found that these pop-
ulations were reduced in Notch2 heterozygousprecursors, CD1dhi fraction of type 2 transitional B
cells. Among Notch target genes, the expression level (Notch2/) B cells, and that Notch2/ B cells in other
fractions develop normally without compensatory upreg-of Deltex1 is prominent in MZB cells and strictly depen-
dent on that of Notch2, suggesting that Deltex1 may ulation of other Notch genes. Among Notch target genes
we studied, only Deltex1 expression is prominent in MZBplay a role in MZB cell differentiation.
cells and strictly dependent on the expression level of
Notch2. These results strongly suggest that amongIntroduction
Notch family members, Notch2 is preferentially ex-
pressed in mature B cells and control MZB developmentThe Notch family genes encode evolutionarily con-
served transmembrane receptors that play a key role in depending on its expression level through interacting
with both RBP-J and Deltex1.cellular differentiation. The interaction of Notch receptor
with its ligand induces the cleavage of the transmembrane
unit of the receptor, which results in the release of Notch Results
intracellular fragment (NIC). NIC translocates to the nu-
cleus and, together with RBP-J, upregulates the expres- Notch Expression in Lymphocyte Development
sion of Hes1, Hes5, and NF-B2 (Artavanis-Tsakonas et Reports describing the expression of Notch genes in
al., 1999; Mumm and Kopan, 2000). Alternatively, NIC lymphatic tissues have not referred to their expression
inhibits the Jun N-terminal kinase (JNK) pathway in as- levels in multiple fractionated T and B cells (Bertrand et
sociation with Deltex1 in an RBP-J-independent manner al., 2000; Cheng et al., 2001; Ohishi et al., 2000). We
(Ordentlich et al., 1998; Osborne and Miele, 1999). therefore examined the amount of Notch1-4 transcripts
Notch is assumed to regulate multiple cell fate deci- in various T and B cell fractions using a real-time PCR
method. Notch1 expression level was generally higher
in T cells than in B cells and prominent in the CD4CD8*Correspondence: hhirai-tky@umin.ac.jp
Immunity
676
Figure 1. Notch Expression in Lymphocyte Fractions and Generation of Notch2 Conditional Knockout Mice
(A–C) Real-time PCR analysis of (A) Notch1, (B) Notch2, (C) Notch3 transcripts in lymphocytes from C57BL/6 mice. Pro, CD43B220int pro-B
cells; Pre, CD43B220intIgM/lo pre-B cells; Imm, CD43B220intIgMhi immature B cells; Mat, CD43B220hiIgMint mature B cells; T1, IgMhi
CD21CD23 type 1 transitional B cells; T2, IgMhiCD21hiCD23hi type 2 transitional B cells; FO, CD21int/hiCD23hi follicular B cells; MZ, IgMhiCD21hi
CD23lo/ marginal zone B cells; CD4CD8, CD4CD8 T cells; CD4CD8, CD4CD8 T cells; CD4, CD4CD8 T cells; CD8, CD4CD8
T cells; B1a, B220IgMCD5 B1a-B cells; B1b, B220IgMCD5 B1b-B cells; BM, bone marrow; Sp, spleen; PE, peritoneal cavity; Th, thymus.
Data are mean SD from triplicate experiments. Mean expression of total splenocytes was defined as 1 AU.
(D) Targeted insertion of loxP sequences flanking the exons coding the transmembrane domain of Notch2. Organization of the wild-type
Notch2 locus, targeting vector, and the locus deleted by Cre-mediated recombination is shown schematically. The hybridization probe used
for Southern blot analysis is indicated. Solid triangles denote loxP sequences. Restriction enzymes: E, EcoRI.
(E) Southern blot analysis was performed on genomic ES cell DNA extracted from Notch2/f (lane 1), Notch2/ (lane 2), and Notch2/ (lane 3).
(F) Expression of Notch2 in cells from Notch2/ embryos. Protein extracts from Notch2/ embryo (lane 1), Notch2/ embryo (lane 2), and
Notch2/ embryo (lane 3) were blotted to filters. Notch2 was visualized with the Notch2 mAb C651.6DbHN.
T cell subset (Figure 1A). Notch1 transcripts decreased (cKO) mice which specifically lack Notch2 expression
in hematopoietic cell population, since Notch2 knockoutduring B cell maturation in the bone marrow and were
sustained at low levels throughout B cell development mice are embryonic lethal.
in the spleen (Figure 1A). Although it was reported that
Notch2 expression is limited to late pre-B cells during Generation of Notch2 Conditional Knockout Mice
To generate mice with tissue-specific deletion of Notch2,B cell development in the human bone marrow (Bertrand
et al., 2000), our study showed that Notch2 displayed a loxP sites were inserted to flank the exons encoding the
transmembrane portion of the Notch2 receptor in mousereciprocal expression pattern to Notch1. Notch2 expres-
sion level increased with B cell maturation and was embryonic stem (ES) cells by homologous recombina-
tion (Figure 1D). ES clones with loxP-flanked Notch2prominent in mature B cell subsets in the spleen, while
remaining low in the thymus (Figure 1B). Notch3 expres- locus (Notch2f) and loxP-deleted Notch2 locus (Notch2)
were used to generate chimeric mice, and the mutantsion pattern was similar to that of Notch1, and Notch4
was barely expressed in all lymphocyte fractions exam- mouse lines were established through germline trans-
mission (Figure 1E). Immunoblotting of Notch2/ em-ined (Figure 1C and data not shown). Given that Notch1
has an indispensable function in early T cell develop- bryo confirmed that loss of the loxP-flanked exons re-
sults in the inactivation of Notch2 gene (Figure 1F).ment, these data suggest that Notch2 plays a major
role in the development of mature B cells. To test this Notch2 mutant mice (Notch2m/m) in which the Notch2
gene is inactivated by replacing the ankyrin repeat se-hypothesis, we generated Notch2 conditional knockout
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quences with the -galactosidase gene were reported
to be embryonic lethal (Hamada et al., 1999). Consistent
with this report, no viable Notch2/ mice were born,
and all Notch2/ mice died in utero around E11.5 of
gestation (data not shown).
Normal T Cell Development in Notch2 cKO Mice
Specific inactivation of either Notch1 or RBP-J in the
bone marrow results in the impairment of early T cell
development and ectopic differentiation of B cells in the
thymus (Han et al., 2002; Radtke et al., 1999). Given that
both Notch1 and Notch2 are expressed in the thymus
(Kaneta et al., 2000) and that RBP-J is the main effector
molecule in the Notch signaling pathway, we examined
T cell differentiation in the thymus of Notch2 cKO mice.
To induce Notch2 deletion in the hematolymphoid pro-
genitor stage, Notch2f/ mice were bred with Mx-Cre
transgenic mice harboring the Cre-recombinase trans-
gene driven by the interferon-inducible Mx promoter
(Kuhn et al., 1995). Although the deletion efficiency of
the floxed region by an IFN- inducer poly(I)-poly(C)
was relatively low in the thymus of Notch1 cKO mice
(approximately 30%) (Radtke et al., 1999) and RBP-J
cKO mice (approximately 60%) (Han et al., 2002), we
observed almost complete deletion of the floxed Notch2
exons in the thymus, suggesting that Notch2 is dispens-
able for thymocyte development and thus that Notch2/
T cells normally develop in the thymus (Figure 2A). As
expected, the absolute number of total thymocytes and
the proportion of T cell subsets in the thymus were
Figure 2. Normal T Cell Development in Notch2 Conditional Knock-equivalent in Notch2f/, Mx-Cre and control mice, and
out Miceno accumulation of B cells was observed in the thymus
(A) Tissue-specific deletion of Notch2. Notch2/, Mx-Cre (lanes 1,(Figures 2B and 2C). These data show that Notch2/
3, 5, and 7) and Notch2f/, Mx-Cre (lanes 2, 4, 6, and 8) were injectedcells can organize normal thymocyte fractions and fur-
intraperitoneally four times with 250g of poly(I)-poly(C). One month
ther indicate that Notch2 activity does not regulate B/T after deletion had been induced, genomic DNA from indicated or-
lineage specification as Notch1 does. gans of these mice were digested with EcoRI and hybridized with
the probe used in Figure 1E.
(B) Absolute numbers of total thymocytes from Notch2/, Mx-Cre
MZB Cell Defect in Notch2 cKO Mice mice (open bar) and Notch2f/, Mx-Cre mice (solid bar). Data are
Notch1/ B cells were reported to normally develop mean SD from three independent experiments.
(C) FACS analysis of thymocytes in Notch2 cKO mice. Thymocyteswithout data in detail (Radtke et al., 1999), but the ab-
were analyzed by FACS for the expression of CD4, CD8, CD3, B220,sence of RBP-J led to the reduction of MZB cells (Tani-
and TCR	. BM, bone marrow; LNs, lymph nodes. The numbersgaki et al., 2002). Thus, we examined B cell differentia-
denote the percentages of cells in the indicated regions.
tion in Notch2 cKO mice. B cells in the bone marrow
developed normally in Notch2f/, Mx-Cre mice (data not
shown). When splenocytes from Notch2f/, Mx-Cre were in the spleen of Notch2/ mice, confirming loss of MZB
cells in the mice with Notch2/ B cells (Figure 4C).analyzed, we found that MZB cells were markedly re-
duced (Figure 3A). Given that Mx-Cre deletes the floxed It has been reported that Notch signaling induces the
expression of CD21 (Makar et al., 2001; Strobl et al.,genomic sequences in all hematopoietic lineages, the
reduction of MZB cells in Notch2f/, Mx-Cre mice could 2000). Our analysis revealed that both follicular B (FOB)
cells in the spleen and peripheral blood B cells fromresult from either a B cell autonomous defect or a defect
in the other components residing in the splenic marginal Notch2/ mice showed a reduced expression level of
CD21, while the expression of CD23 was not alteredzone, such as T cells, macrophages, stromal cells, and
other nonlymphoid cells. To distinguish these possibili- (Figure 3C). This result is compatible with a report show-
ing that the activated form of Notch1 was able to upregu-ties, Notch2 floxed mice were mated with CD19-Cre
mice, inducing B lineage-specific deletion of the loxP- late the expression of CD21 but not CD23 (Strobl et al.,
2000). Recently, it was reported that MZB cells expressflanked target sequence (Rickert et al., 1997). MZB cells
were almost absent in Notch2f/, CD19-Cre mice integrin receptors L2 and 41 to reside in the mar-
ginal zone (Lu and Cyster, 2002). However, the expres-(Notch2/ mice) (Figure 3B). Consistent with this, the
IgMhiIgDlo fraction III population (F-III) comprising T1 B sion levels of integrin subunits L, 4, 1, 2, and 7
were not altered in Notch2/ splenic B cells (data notcells and MZB cells decreased in number (Figure 3B).
Histological examination showed complete absence of the shown). Taken together, these experiments demon-
strate that Notch2/ B cells have a cell-autonomouscharacteristic perifollicular rim consisting of IgMhiIgDlo cells
Immunity
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Figure 3. MZB Cell Defect in Notch2 Conditional Knockout Mice
(A and B) FACS analysis of NFB, FOB, and MZB cells in Notch2 cKO mice. Splenocytes were analyzed by FACS for the expression of B220,
CD21, CD23, IgD and IgM. The profiles using anti-CD21 and anti-CD23 were performed on samples of B220 cells. NFB, FOB, and MZB cells
were defined as CD21CD23, CD21int/hiCD23hi, and CD21hiCD23lo/, respectively. The numbers denote the percentages of cells in the indicated
squares. F-I, -II, -III; Fraction I, II, III.
(C) Reduced expression of CD21 and normal expression of CD23 on FOB cells (B220CD23hi) and peripheral blood B cells from Notch2f/,
CD19-Cre mice. (Left panels) Histograms of indicated cell fractions are from Notch2/, CD19-Cre mice (solid line), Notch2f/, CD19-Cre mice
(bold line), and negative control (dotted line). (Right panels) CD21 expression of the indicated B cell fraction from Notch2/, CD19-Cre mice
(open bar) and Notch2f/, CD19-Cre mice (solid bar). Data are mean SD from three independent experiments. MFI, mean fluorescence
intensity.
defect in MZB development and express CD21 at de- Robey, 1999), we analyzed the effects of Notch1 and
Notch2 heterozygous defect on MZB cell development.creased levels compared with wild-type B cells.
The numbers of MZB cells in the spleen from Notch2/f,
CD19-Cre mice (Notch2/ mice) ranged from one-sixthNotch2 Haploinsufficiency Causes MZB
Cell Reduction to one-fourth of those in the control mice (Figures 4A
and 4B). In agreement with the cytometric results, histo-Since the amount of Notch has been reported to affect
cell fate determination (Artavanis-Tsakonas et al., 1999; logical examination showed that IgMIgD MZB cells
Notch2 Is Indispensable for MZB Cell Development
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Figure 4. Notch2 Haploinsufficiency Causes MZB Cell Reduction
(A) FACS analysis of NFB, FOB, and MZB cells in Notch2 cKO mice, Notch2 mutant mice, and Notch1 knockout mice.
(B) Absolute numbers of NFB, FOB, and MZB cells. Numbers were calculated by multiplying the fraction of each FACS B cell subset analyzed
in (A) by the total number of B220 cells. Notch2/, B cells from Notch2/, CD19-Cre mice; Notch2/, B cells from Notch2/f, CD19-Cre
mice; Notch2/, B cells from Notch2f/, CD19-Cre mice. Data are mean SD from four independent experiments.
(C) Immunofluorescent histochemistry performed on nonimmunized splenic cryosections with Alexa Fluor 594-anti-IgM and FITC-anti-IgD.
(D) Measurement of Notch2 transcripts from wild-type allele. RT products from the cells in the B cell fractions were assayed by real-time PCR
using a primer pair that recognizes the deleted region present only in the wild-type transcripts.
are reduced in the spleen of Notch2/ mice (Figure 4C). Presumed MZB Precursor Defect in Notch2 cKO Mice
We then examined a CD1dhiCD9hi fraction in the splenicIn Notch2/m mice, the number of MZB cells was also
reduced to the same degree, which is consistent with B cells, since it has been reported that MZB cells ex-
press high levels of CD1d and CD9 (Roark et al., 1998;the phenotype observed in Notch2/ mice. In contrast,
the number of MZB cells was not altered in Notch1/ Won and Kearney, 2002). We found that CD1dhi B cells
expressed a high level of CD9 and that CD1dhiCD9hi cellsmice (Figure 4A).
To test the level of Notch2 transcripts in Notch2/ B emerged as a unique population (Figure 5A, left). As
expected, this population was reduced in number withcell, cDNAs reverse-transcribed (RT) with mRNA from
the cells in the B cell fractions were examined by real- dependence on the Notch2 gene dosage (Figure 5A).
Interestingly, over 90% of CD1dhiCD9hi B cells were losttime PCR using a primer pair that recognizes only the
wild-type Notch2 transcripts. Wild-type Notch2 tran- in Notch2/ splenic B cells (Figure 5A, right), which
could not be explained by only the defect of MZB cells,scripts from Notch2/ B cell fractions were approxi-
mately half of those from Notch2/ B cell fractions since no more than two-thirds of CD1dhi cells are re-
ported to be MZB cells (Amano et al., 1998). Indeed,(Figure 4D). Taken together, these results suggest that
the haploinsufficiency of Notch2 leads to the reduction approximately 70% of CD1dhi cells were IgMhiIgDlo
CD21hiCD23lo/; i.e., MZB, and the majority of the otherof MZB cells in the spleen of Notch2/ mice.
Immunity
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Figure 5. Presumed MZB Precursor Defect in Notch2 Conditional Knockout Mice
(A) CD1d and CD9 staining profiles in B220 cells. Erythrocyte-depleted splenocytes were stained with antibodies to B220, CD1d, and CD9.
(B) IgM and IgD staining profiles in CD1dhiCD23lo/ or CD1dhiCD23hi splenic lymphocytes. Erythrocyte-depleted splenocytes were stained with
antibodies to CD1d, CD23, IgM, and IgD.
(C) CD21 and CD23 staining profiles in CD1dhi cells. Erythrocyte-depleted splenocytes were stained with antibodies to CD1d, CD21, and CD23.
(D) The percentage of pre-MZB and MZB cells was calculated from the FACS data in (C) and the total number of CD1dhi splenic lymphocytes.
Data are mean SD from four independent experiments.
(E) CD21 and IgM staining profiles in the indicated mice. Erythrocyte-depleted splenocytes were stained with antibodies against CD21, CD23,
and IgM. T2 B cells are shown in the box, and the percentage of T2 B cells is also shown.
(F) The absolute numbers of splenic T2 B cells were calculated from the FACS data in (E) and the total number of erythrocyte-depleted
splenocytes. Data are mean SD from four independent experiments.
CD1dhi cells showed IgMhiIgDhiCD21hiCD23hi phenotype We next examined whether deficiency of Notch2 af-
fected the total T2 B fraction. The number of T2 B cells(Figures 5B and 6C, left), representative of some T2 B
cells (Loder et al., 1999). Remarkably, the CD1dhi T2 B was reduced in Notch2/ mice compared with the con-
trol mice (Figures 5E and 5F). Together, these data showcells also decreased in a Notch2 gene dosage-depen-
dent manner, although their reduction in the Notch2/ that Notch2/ mice lack CD1dhi T2 B cells, suggesting
that this fraction is corresponding to the direct precur-mice appeared to be milder than that of MZB cells,
suggesting that CD1dhi T2 B cells are less sensitive to sors of MZB cells (pre-MZB), and that both defect of
CD1dhi T2 B cells and reduction of CD21 expressionthe reduction of Notch2 signal than MZB cells (Figures
5C and 5D). We observed almost complete absence of level in the total FOB cells (Figure 3C) contribute to the
decrease of the total number of T2 B cells.CD1dhi T2 B cells in Notch2/ mice.
Notch2 Is Indispensable for MZB Cell Development
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Figure 6. Notch Signal Is Dispensable in Other B Cell Fractions
(A) Representative flow cytometric analysis of IgM and CD21 on CD23 splenocytes for T1 B cells, IgM, and Syndecan-1 on splenocytes for
plasma cells and IgM and CD5 on cells from peritoneal cavity for B1 cells. The percentages of each cell type are shown.
(B) Relative amounts of Notch1 transcripts were measured using real-time PCR.
(C) A model for MZB cell development is shown schematically.
Notch Signaling Is Dispensable for Development Deltex1 Is Expressed in MZB Cells and Regulated
by Notch2of Other B Cell Lineages
In addition to the fact that the FOB cells are normal in To further characterize the effects downstream of Notch
signaling in mature B cells, we analyzed the expressionnumber, we found that other intra- and extrasplenic B
cells, such as T1 B cells, splenic plasma cells, and perito- of Notch effector genes. Equal amounts of RBP-J tran-
scripts were detected in all fractions of splenic B cells,neal cavity B1 B cells were quantitatively normal in
Notch2/ mice (Figure 6A). Moreover, no differentiation and RBP-J expression was not altered in Notch2/ B
cells (Figure 7A). Hes1 and Hes5 are suggested to bedefects in B lineage lymphocytes other than in MZB
lineage cells were found in Notch2/ mice. To investi- immediate downstream targets of Notch2 (Shimizu et
al., 2000; Tan-Pertel et al., 2000). The induction of Hes1/gate the potential compensation by transcriptional
upregulation of other Notch family members in these Hes5 leads to the perturbation of B cell development
(Kawamata et al., 2002). We found that Hes1 transcriptsfractions, RT products from T1 B, T2 B, FOB, and MZB
fractions were analyzed for the expression levels of hold a low level in developing B cells in the bone marrow
(Figure 7B) in contrast to the observation that dramaticNotch1, Notch3, and Notch4. The amount of RNA of
these genes was not detectably altered by Notch2 de- change in Hes1 expression level was shown using high-
density oligonucleotide array (Hoffmann et al., 2002).fect, excluding the presence of a compensatory mecha-
nism (Figure 6B and data not shown). These results Although Hes1 and Hes5 were constitutively expressed
at moderate levels in mature B cells, their expressionindicate that, since only Notch2 among Notch family of
genes is specifically expressed at a high level in mature levels were not significantly altered by the defect of
Notch2 (Figures 7B and 7C). The same samples wereB cells, Notch signaling might be dispensable for the
development of B cell fractions other than MZB lineage also analyzed for the expression of Deltex1, which is a
Notch signal modulator and also a transcriptional targetcells.
These results indicate that in mature B cells, the Notch of Notch. Surprisingly, Deltex1 transcriptional expres-
sion mirrors Notch2 expression in mature B cells, i.e.,signal is transmitted mainly through the Notch2 recep-
tor. When the intensity of the Notch2 signal is decreased reduced by half in Notch2/ B cells and minimized in
Notch2/ B cells (Figure 7D). This shows that Deltex1by half, pre-MZB and MZB cell differentiation would be
impaired, especially at the latter stage. When the Notch expression is tightly regulated by Notch2 and barely
influenced by other Notch family members in maturesignal is fully abolished by Notch2 defect, MZB cell
differentiation is totally blocked before the pre-MZB B cells. We found that Notch2 transcripts were most
prominent in the MZB subset, followed by T2 B cellstage. In contrast, other mature B cells, such as FOB
cells, plasma cells, and B1 cells are fully differentiated subset (Figure 7D).
These results demonstrate that in the T2 B cell frac-even without transcriptional compensation of other
Notch family members (Figure 6C). tion, which includes a presumed MZB precursor subset,
Immunity
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al., 2002; Tanigaki et al., 2002). Since Notch1 cKO mice
were reported to show impairment of T cell development
without that of MZB cell development (Radtke et al.,
1999), it was conceivable that another Notch receptor
is responsible for MZB cell differentiation. We found that
Notch2 cKO mice showed defect in MZB cell develop-
ment without that of T cell development. These results
clearly disclosed that among Notch family members,
Notch2 is essential for MZB cell differentiation and that
RBP-J is the main effector in Notch2 signaling. Since
Notch1 is preferentially expressed in immature T cells
and Notch2 in mature B cells, it was suggested that
Notch1 and Notch2 have a functionally distinct role in
lymphocyte development, probably through their differ-
ent expression patterns and/or peculiar regulatory fash-
ions in lymphopoiesis. In our study, Notch2 cKO mice
showed additional B cell phenotypes, which were not
described in the study of RBP-J cKO mice, such as the
reduced level of CD21 expression and the decreased
number of T2 B cells. These phenotypes might be attrib-
uted to the Deltex1 inactivation, since Deltex1 is re-
ported to be responsible for an RBP-J-independent
Notch signaling pathway (Ordentlich et al., 1998). We
did not observe an increase of FOB cells in number,
which was observed in RBP-J cKO mice (Tanigaki et
al., 2002). However, since MZB represents a minority of
splenic B cells, it is possible that there is an immeasur-
able increase of FOB cells at the expense of MZB cells.
However, direct comparison of RBP-J cKO mice and
Notch2 cKO mice is required to confirm the difference
beforehand.
Inactivation of the proteins listed below results in the
decrease or defect of MZB cells with spared FOB cells.
(1) Migration and chemokine receptor related proteins:
Dock2 (Fukui et al., 2001), Lsc (Girkontaite et al., 2001),
Pyk2 (Guinamard et al., 2000). (2) BCR signaling related
proteins: Aiolos (Wang et al., 1998), Ig mutant (Kraus
et al., 2001), Lyn (Seo et al., 2001), CD19 (Makowska et
al., 1999; Martin and Kearney, 2000), CD22 (Samardzic
et al., 2002), Rac2 (Croker et al., 2002). (3) NFB family:
NFB p50, NFB p65 (RelA), c-Rel (Cariappa et al., 2000),
RelB (Weih et al., 2001). (4) Notch signaling related pro-
teins: RBP-J (Tanigaki et al., 2002), Notch2 (this paper).
Recently, it was shown that the interactions of LFA1
(integrin L2)-ICAM1 and integrin 41-VCAM1 are re-
quired for MZB cells to localize in the splenic marginalFigure 7. Deltex1 Expression Is Prominent in MZB Cells and Regu-
zone (Lu and Cyster, 2002). Integrin-mediated retentionlated by Notch2
of MZB cells agrees well with the MZB cell loss in miceReal-time PCR analysis of (A) RBP-J, (B) Hes1, (C) Hes5, and (D)
lacking the genes classified in (1). Although we cannotDeltex1 transcripts in each subsets from indicated mouse line. Data
completely exclude the possibility of the interaction be-are mean SD from triplicate experiments. Notch2/, B cells from
Notch2/, CD19-Cre mice; Notch2/, B cells from Notch2/f, CD19- tween Notch and these factors, there were no altered
Cre mice; Notch2/, B cells from Notch2f/, CD19-Cre mice. expression levels of integrinL2 and 41 in Notch2/
B cells. Investigators have proposed that MZB cell dif-
ferentiation is inhibited by excess of B cell receptor
Hes1/Hes5 expression level is not significantly de- (BCR) signaling (Cariappa et al., 2001), and thus the
creased by Notch2 defect, whereas Deltex1 expression reason for MZB cell loss in mice lacking the genes listed
is tightly regulated by Notch2 activity and prominent in in (2) could be due to aberrant BCR signaling although
MZB cells, suggesting that Deltex1 should play a role this theory is controversial (Rickert et al., 1995; Sato
in MZB cell differentiation. et al., 1997). A decreased expression level of CD21 in
Notch2/ B cells might be caused by a negative feed-
Discussion back phenomenon with increased BCR signaling (Cari-
appa et al., 2001) induced by Notch2 inactivation or by
Recently, RBP-J cKO mice were reported to show im- lack of direct positive regulation through RBP-J,
whereas CD21 expression was reported to be unre-pairment of both T and MZB cell development (Han et
Notch2 Is Indispensable for MZB Cell Development
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San Diego, CA). IgM expression was revealed with Alexa Fluor 594-duced in RBP-J cKO mice (Tanigaki et al., 2002). Al-
conjugated streptavidine (Molecular Probes, Eugene, OR) diluted tothough the mechanism by which the defect of NFB
1:250. Slides were analyzed with a Bio-Rad confocal laser scanningcould be translated into MZB cell loss has not been
microscope, MRC-1024 (BioRad, Hercules, CA).
shown, NFB is closely linked to the Notch signaling
pathway (Bash et al., 1999; Cheng et al., 2001; Guan et Immunoblotting
al., 1996; Oswald et al., 1998; Wang et al., 2001), and Embryos were lysed for 30 min in 1 ml of ice-cold lysis buffer con-
taining 1% Triton X-100. After centrifugation, lysates were subjectedthus, the phenotypes from mice lacking the genes classi-
to 6.75% SDS-poly-acrylamide gel electrophoresis and transferredfied in (3) are assumed to be relevant to those from
to a PVDF membrane (Millipore, Bedford, MA). The blot was incu-Notch2/ mice.
bated with the Notch2 mAb C651.6DbHN (Iowa University) and visu-
The possibility of redundant function of Notch pro- alized by alkaline phosphatase-conjugated secondary antibody
teins complicates their functional analyses. We found (Promega, Madison, WI).
normal FOB cell development in Notch2/ mice despite
Cell Sortinga high expression level of Notch2 in this fraction. As for
Each indicated subset was isolated on FACSVantage (Becton Dick-FOB cell development, our study suggests that FOB cell
inson, San Diego, CA). For experiments examining mRNA expressionmaturation is not a result of the redundant function of
in sorted cells, 5 
 104 – 2 
 105 cells from each fraction wereNotch family members but that the Notch signal might
subjected to real-time PCR analysis.
be dispensable for FOB cell maturation.
It has been suggested that some fractions of splenic RNA Analysis
FOB cells might be the MZB precursors (Cariappa et Total cellular RNA was extracted with RNeasy (Qiagen, Hilden, Ger-
many) and converted into cDNAs by reverse transcriptase (Super-al., 2001; Dammers et al., 1999). However, the character-
script II, Invitrogen, Carlsbad, CA). Real-time PCR was performedistics of the direct MZB precursors are not well defined.
using the ABI PRISM 7000 Sequence Detection System (AppliedWe have shown that the inactivation of Notch2 leads
Biosystems, Foster City, CA) according to the manufacturer’s in-
not only to the defect of MZB cells but also to the defect structions. Amplification of -actin cDNA was used as the endoge-
of a particular fraction of FOB cells that can be catego- nous normalization standard. The 25 l amplification reaction mix-
rized as CD1dhi T2 B cells, suggesting this fraction to ture contained 5 l of cDNA (1:10 dilution), 12.5 l of SYBR Green
PCR master mix, or Taqman universal PCR master mix (Appliedbe the direct precursors of MZB cells.
Biosystems, Foster City, CA), and 1 l each (400 nM) of primers.
Each sample was amplified in triplicate using primers and probesExperimental Procedures
specific for Notch1-4, RBP-J, Hes1, Hes5, Deltex1, and -actin.
A two-step cycling protocol with combined primer annealing andGeneration of Notch2 cKO Mice
elongation at 60C was used.To construct a targeting vector for homologous recombination, two
loxP sites were inserted into the genomic fragment of mouse Notch2
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